18 May 2020 --- Norwegian biotech company Hofseth Biocare (HBC) has published its Q1 financial results. In collaboration with its distributor Prinova Europe, the company anticipates profitability this year, with its first US orders booked. Moreover, the company is investing in its long-term R&D with several initiated, ongoing and approved research projects. Continuing its conversation from last week, the company tells NutritionInsight that it considers its first quarter results as positive and improve the company’s position to deliver environmentally sustainable marine ingredients.
